Diligence memo · auto-generated · as of July 3, 2026
Strategic Pharmaceutical Solutions, Inc
Strategic Pharmaceutical Solutions, Inc looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Strategic Pharmaceutical Solutions, Inc operates in Pharma, based in Portland.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Strategic Pharmaceutical Solutions, Inc has raised $23M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $10M on 2010-04-08.
Most recent recorded round closed around 2018-03-02.
Valuation (modeled)modeled
Provath models Strategic Pharmaceutical Solutions, Inc at approximately $46M (range $1.7M–$251M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.25× the median modeled value of Series A Pharma companies in 2016–2018 (14 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 32 months.
Last raise 8.3 yr ago; this sector typically re-raises about every 16 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.3× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 78% of Pharma peers (310 compared).
Modeled value ranks above 55% of those peers.
Closest niche peers: Qool Therapeutics, Inc., SpringWorks Therapeutics, LLC, Caliber Therapeutics, Inc., Rodin Therapeutics, Inc., SmartPharm Therapeutics, Inc..
Peoplefiled
11 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.